Crystal Structure of Human RhoA in a Dominantly Active Form Complexed with a GTP Analogue*

The 2.4-Å resolution crystal structure of a dominantly active form of the small guanosine triphosphatase (GTPase) RhoA, RhoAV14, complexed with the nonhydrolyzable GTP analogue, guanosine 5′-3-O-(thio)triphosphate (GTPγS), reveals a fold similar to RhoA-GDP, which has been recently reported (Wei, Y., Zhang, Y., Derewenda, U., Liu, X., Minor, W., Nakamoto, R. K., Somlyo, A. V., Somlyo, A. P., and Derewenda, Z. S. (1997) Nat. Struct. Biol. 4, 699–703), but shows large conformational differences localized in switch I and switch II. These changes produce hydrophobic patches on the molecular surface of switch I, which has been suggested to be involved in its effector binding. Compared with H-Ras and other GTPases bound to GTP or GTP analogues, the significant conformational differences are located in regions involving switches I and II and part of the antiparallel β-sheet between switches I and II. Key residues that produce these conformational differences were identified. In addition to these differences, RhoA contains four insertion or deletion sites with an extra helical subdomain that seems to be characteristic of members of the Rho family, including Rac1, but with several variations in details. These sites also display large displacements from those of H-Ras. The ADP-ribosylation residue, Asn41, by C3-like exoenzymes stacks on the indole ring of Trp58 with a hydrogen bond to the main chain of Glu40. The recognition of the guanosine moiety of GTPγS by the GTPase contains water-mediated hydrogen bonds, which seem to be common in the Rho family. These structural differences provide an insight into specific interaction sites with the effectors, as well as with modulators such as guanine nucleotide exchange factor (GEF) and guanine nucleotide dissociation inhibitor (GDI).

[1]  J. Cherfils,et al.  Crystal structures of the small G protein Rap2A in complex with its substrate GTP, with GDP and with GTPγS , 1997, The EMBO journal.

[2]  W. Minor,et al.  Crystal structure of RhoA–GDP and its functional implications , 1997, Nature Structural Biology.

[3]  S. Smerdon,et al.  Crystal structure of a small G protein in complex with the GTPase-activating protein rhoGAP , 1997, Nature.

[4]  K. Aktories,et al.  Rho proteins: targets for bacterial toxins. , 1997, Trends in microbiology.

[5]  M. Rosen,et al.  C-terminal binding domain of Rho GDP-dissociation inhibitor directs N-terminal inhibitory peptide to GTPases , 1997, Nature.

[6]  C. Fiorentini,et al.  Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine , 1997, Nature.

[7]  M. Mann,et al.  Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1 , 1997, Nature.

[8]  K. Nakao,et al.  p140mDia, a mammalian homolog of Drosophila diaphanous,is a target protein for Rho small GTPase and is a ligand for profilin , 1997, The EMBO journal.

[9]  G. Roberts,et al.  A modulator of rho family G proteins, rhoGDI, binds these G proteins via an immunoglobulin-like domain and a flexible N-terminal arm. , 1997, Structure.

[10]  K. Kaibuchi,et al.  Formation of Actin Stress Fibers and Focal Adhesions Enhanced by Rho-Kinase , 1997, Science.

[11]  Y. Zheng,et al.  Residues of the Rho Family GTPases Rho and Cdc42 That Specify Sensitivity to Dbl-like Guanine Nucleotide Exchange Factors* , 1997, The Journal of Biological Chemistry.

[12]  M. Hirshberg,et al.  The crystal structure of human rac1, a member of the rho-family complexed with a GTP analogue , 1997, Nature Structural Biology.

[13]  X. Q. Chen,et al.  The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton , 1996, Molecular and cellular biology.

[14]  K. Fujisawa,et al.  Identification of the Rho-binding Domain of p160ROCK, a Rho-associated Coiled-coil Containing Protein Kinase* , 1996, The Journal of Biological Chemistry.

[15]  Yoshiharu Matsuura,et al.  Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)* , 1996, The Journal of Biological Chemistry.

[16]  A. Abo,et al.  Rac “Insert Region” Is a Novel Effector Region That Is Implicated in the Activation of NADPH Oxidase, but Not PAK65* , 1996, The Journal of Biological Chemistry.

[17]  A. Hall,et al.  Rho: a connection between membrane receptor signalling and the cytoskeleton. , 1996, Trends in cell biology.

[18]  S. Narumiya The small GTPase Rho: cellular functions and signal transduction. , 1996, Journal of biochemistry.

[19]  Ralf Janknecht,et al.  Ras/Rap effector specificity determined by charge reversal , 1996, Nature Structural Biology.

[20]  Kozo Kaibuchi,et al.  Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase) , 1996, Science.

[21]  K. Fujisawa,et al.  Rhotekin, a New Putative Target for Rho Bearing Homology to a Serine/Threonine Kinase, PKN, and Rhophilin in the Rho-binding Domain* , 1996, The Journal of Biological Chemistry.

[22]  T. Yamamoto,et al.  Rho‐associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. , 1996, The EMBO journal.

[23]  Y. Zheng,et al.  The Dbl family of oncogenes. , 1996, Current opinion in cell biology.

[24]  K. Fujisawa,et al.  The small GTP‐binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. , 1996, The EMBO journal.

[25]  G. Bokoch,et al.  Physical association of the small GTPase Rho with a 68-kDa phosphatidylinositol 4-phosphate 5-kinase in Swiss 3T3 cells. , 1996, Molecular biology of the cell.

[26]  K. Kaibuchi,et al.  Identification of a Putative Target for Rho as the Serine-Threonine Kinase Protein Kinase N , 1996, Science.

[27]  K. Fujisawa,et al.  Protein Kinase N (PKN) and PKN-Related Protein Rhophilin as Targets of Small GTPase Rho , 1996, Science.

[28]  K D Cowtan,et al.  Phase combination and cross validation in iterated density-modification calculations. , 1996, Acta crystallographica. Section D, Biological crystallography.

[29]  Shuh Narumiya,et al.  A novel partner for the GTP‐bound forms of rho and rac , 1995, FEBS letters.

[30]  S. Sprang,et al.  Tertiary and Quaternary Structural Changes in Giα1 Induced by GTP Hydrolysis , 1995, Science.

[31]  A. Wittinghofer,et al.  The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with RaplA and a GTP analogue , 1995, Nature.

[32]  M. Mann,et al.  Glucosylation of Rho proteins by Clostridium difficile toxin B , 1995, Nature.

[33]  T. Sasaki,et al.  Rho as a regulator of the cytoskeleton. , 1995, Trends in biochemical sciences.

[34]  M. Olson,et al.  Direct Involvement of the Small GTP-binding Protein Rho in lbc Oncogene Function (*) , 1995, The Journal of Biological Chemistry.

[35]  W. Kabsch,et al.  Crystal structure of the nuclear Ras-related protein Ran in its GDP-bound form , 1995, Nature.

[36]  D. Ringe,et al.  Structure of the human ADP-ribosylation factor 1 complexed with GDP , 1994, Nature.

[37]  L. Chong,et al.  The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells , 1994, Cell.

[38]  S. Sprang,et al.  Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis. , 1994, Science.

[39]  Heidi E. Hamm,et al.  Structural determinants for activation of the α-subunit of a heterotrimeric G protein , 1994, Nature.

[40]  Jonathan A. Cooper,et al.  A single amino acid change in Raf-1 inhibits Ras binding and alters Raf-1 function. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  K. Aktories,et al.  Probing the action of Clostridium difficile toxin B in Xenopus laevis oocytes. , 1994, Journal of cell science.

[42]  John G. Collard,et al.  Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins , 1994, Cell.

[43]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[44]  T. Sasaki,et al.  The Dbl oncogene product as a GDP/GTP exchange protein for the Rho family: its properties in comparison with those of Smg GDS. , 1994, Biochemical and biophysical research communications.

[45]  L. Lim,et al.  A brain serine/threonine protein kinase activated by Cdc42 and Rac1 , 1994, Nature.

[46]  Heidi E. Hamm,et al.  The 2.2 Å crystal structure of transducin-α complexed with GTPγS , 1993, Nature.

[47]  R. Hilgenfeld,et al.  Crystal structure of active elongation factor Tu reveals major domain rearrangements , 1993, Nature.

[48]  M. Marshall,et al.  The effector interactions of p21ras. , 1993, Trends in biochemical sciences.

[49]  L. Lim,et al.  A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42 , 1993, Nature.

[50]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[51]  A. Hall,et al.  Different structural organization of Ras and Rho effector domains. , 1993, Oncogene.

[52]  T. Sasaki,et al.  Functional interactions of stimulatory and inhibitory GDP/GTP exchange proteins and their common substrate small GTP-binding protein. , 1992, The Journal of biological chemistry.

[53]  J. Vandekerckhove,et al.  Purification and characterization of an ADP-ribosyltransferase produced by Clostridium limosum. , 1992, The Journal of biological chemistry.

[54]  J. Spudich,et al.  Control of nonmuscle myosins by phosphorylation. , 1992, Annual review of biochemistry.

[55]  S. Aaronson,et al.  Catalysis of guanine nucleotide exchange on the CDC42Hs protein by the dbloncogene product , 1991, Nature.

[56]  K. Kaibuchi,et al.  Molecular cloning of the cDNA for stimulatory GDP/GTP exchange protein for smg p21s (ras p21-like small GTP-binding proteins) and characterization of stimulatory GDP/GTP exchange protein. , 1991, Molecular and cellular biology.

[57]  S. Narumiya,et al.  Purification of GTPase-activating protein specific for the rho gene products. , 1991, The Journal of biological chemistry.

[58]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[59]  S H Kim,et al.  Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP. , 1991, Journal of molecular biology.

[60]  S H Kim,et al.  Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. , 1992, Science.

[61]  W. Kabsch,et al.  Three-dimensional structures of H-ras p21 mutants: Molecular basis for their inability to function as signal switch molecules , 1990, Cell.

[62]  Y. Hata,et al.  Regulation of reversible binding of smg p25A, a ras p21-like GTP-binding protein, to synaptic plasma membranes and vesicles by its specific regulatory protein, GDP dissociation inhibitor. , 1990, The Journal of biological chemistry.

[63]  W. Kabsch,et al.  Refined crystal structure of the triphosphate conformation of H‐ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis. , 1990, The EMBO journal.

[64]  A T Brünger,et al.  Slow-cooling protocols for crystallographic refinement by simulated annealing. , 1990, Acta crystallographica. Section A, Foundations of crystallography.

[65]  Steven C. Almo,et al.  Time-resolved X-ray crystallographic study of the conformational change in Ha-Ras p21 protein on GTP hydrolysis , 1990, Nature.

[66]  S. Narumiya,et al.  Asparagine residue in the rho gene product is the modification site for botulinum ADP-ribosyltransferase. , 1989, The Journal of biological chemistry.

[67]  K. Nakao,et al.  Purification and properties of the cytosolic substrate for botulinum ADP-ribosyltransferase. Identification as an Mr 22,000 guanine nucleotide-binding protein. , 1988, The Journal of biological chemistry.

[68]  Y. Takai,et al.  Purification and characterization of a GTP-binding protein with a molecular weight of 20,000 in bovine brain membranes. Identification as the rho gene product. , 1988, The Journal of biological chemistry.

[69]  C. Der,et al.  Biological and biochemical properties of human ras H genes mutated at codon 61 , 1986, Cell.

[70]  R. Axel,et al.  A novel ras-related gene family , 1985, Cell.